Verastem, Inc. - Common Stock (NQ:VSTM)

7.480 -0.280 (-3.61%)

Streaming Delayed Price Updated: 12:47 PM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Volume	610,660
Open	7.670
Bid (Size)	7.470 (800)
Ask (Size)	7.480 (500)
Prev. Close	7.760
Today's Range	7.470 - 7.790
52wk Range	3.455 - 11.24
Shares Outstanding	44,784,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗

December 29, 2025

A full exit during a volatile stretch raises a sharper question than timing alone.

Via The Motley Fool

Verastem Oncology Stock Drops After Hours After Discontinuing A Clinical Trial In Lung Cancer ↗

December 29, 2025

The company discontinued its trial in advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC) following evaluation of interim data.

Via Stocktwits

Performance

YTD	+15.3%	+15.3%
1 Month	-27.5%	-27.5%
3 Month	-13.4%	-13.4%
6 Month	+80.2%	+80.2%
1 Year	+103.8%	+103.8%

More News

Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer

December 29, 2025

From Verastem Oncology

Via Business Wire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects ↗

October 24, 2025

Via Stocktwits

This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗

December 28, 2025

Via The Motley Fool

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗

December 28, 2025

Via The Motley Fool

Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth

December 15, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference

November 25, 2025

From Verastem Oncology

Via Business Wire

Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 14, 2025

Via Benzinga

Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants

November 14, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Proposed Public Offering of Common Stock

November 13, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at Upcoming Investor Conferences

November 05, 2025

From Verastem Oncology

Via Business Wire

Verastem Inc (NASDAQ:VSTM) Reports Q3 2025 Revenue Beat Amid Widened Loss ↗

November 04, 2025

Via Chartmill

Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

November 04, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors

October 23, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025

October 23, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma

October 19, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 07, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology to Present at Upcoming Investor Conferences

August 27, 2025

From Verastem Oncology

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 13, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

August 13, 2025

Via Chartmill

Verastem Oncology Announces Late-Breaking Abstract from Partner GenFleet Therapeutics’ Study in China of GFH375 (VS-7375) in Advanced Non-Small Cell Lung Cancer at IASLC 2025 World Conference on Lung Cancer

August 13, 2025

From Verastem Oncology

Via Business Wire

Verastem Oncology Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates

August 07, 2025

From Verastem Oncology

Via Business Wire

Frequently Asked Questions

Is Verastem, Inc. - Common Stock publicly traded?

Yes, Verastem, Inc. - Common Stock is publicly traded.

What exchange does Verastem, Inc. - Common Stock trade on?

Verastem, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Verastem, Inc. - Common Stock?

The ticker symbol for Verastem, Inc. - Common Stock is VSTM on the Nasdaq Stock Market

What is the current price of Verastem, Inc. - Common Stock?

The current price of Verastem, Inc. - Common Stock is 7.480

When was Verastem, Inc. - Common Stock last traded?

The last trade of Verastem, Inc. - Common Stock was at 12/30/25 12:47 PM ET

What is the market capitalization of Verastem, Inc. - Common Stock?

The market capitalization of Verastem, Inc. - Common Stock is 334.98M

How many shares of Verastem, Inc. - Common Stock are outstanding?

Verastem, Inc. - Common Stock has 335M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.